EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

N 1 ‐Benzoylated 5‐(4‐pyridinyl)indazole‐based kinase inhibitors: Attaining haspin and Clk4 selectivity via modulation of the benzoyl substituents

Habiba G Aboelfotouh iD, Mennatallah Abdallah, Hend Khalifa, Youssef Aboushady, Ashraf H Abadi, Matthias Engel, Mohammad Abdel-Halim

Archiv der Pharmazie · 2024

DOI: 10.1002/ardp.202400020 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archiv der Pharmazie, 2024. Verfasst von Habiba G Aboelfotouh und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Chemistry, Faculty of Pharmacy and Biotechnology, German University in Cairo, Cairo, Egypt. Hauptthemen laut MEDLINE: Indazoles, Protein Kinase Inhibitors, Protein Serine-Threonine Kinases, Protein-Tyrosine Kinases. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: None.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Haspin and Clk4 are both understudied protein kinases (PKs), offering potential targets for the development of new anticancer agents. Thus, the identification of new inhibitors targeting these PKs is of high interest. However, the inhibitors targeting haspin or Clk4 developed to date show a poor selectivity profile over other closely related PKs, increasing the risk of side effects. Herein, we present two newly developed N 1 ‐benzyolated 5‐(4‐pyridinyl)indazole‐based inhibitors ( 18 and 19 ), derived from a newly identified indazole hit. These inhibitors exhibit an exceptional inhibitory profile toward haspin and/or Clk4. Compound 18 (2‐acetyl benzoyl) showed a preference to inhibit Clk4 and haspin over a panel of closely related kinases, with sixfold selectivity for Clk4 (IC 50 = 0.088 and 0.542 μM, respectively). Compound 19 (4‐acetyl benzoyl) showed high selectivity against haspin over the common off‐target kinases (Dyrks and Clks) with an IC 50 of 0.155 μM for haspin. Molecular docking studies explained the remarkable selectivity of 18 and 19 , elucidating how the new scaffold can be modified to toggle between inhibition of haspin or Clk4, despite the high homology of the ATP‐binding sites. Their distinguished profile allows these compounds to be marked as interesting chemical probes to assess the selective inhibition of haspin and/or Clk4.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

IndazolesProtein Kinase InhibitorsProtein Serine-Threonine KinasesProtein-Tyrosine KinasesHumansAntineoplastic AgentsDose-Response Relationship, DrugIntracellular Signaling Peptides and ProteinsMolecular Docking SimulationMolecular StructureStructure-Activity RelationshipPyridines

Stichwörter der Autor:innen

Clk4anticancer agentshaspinindazole derivativeskinase inhibitors

Substanzen

Antineoplastic AgentsClk dual-specificity kinasesIndazolesIntracellular Signaling Peptides and ProteinsProtein Kinase InhibitorsProtein Serine-Threonine KinasesProtein-Tyrosine KinasesPyridinesHASPIN protein, human

Autor:innen und Institutionen

  • Department of Pharmaceutical Chemistry, Faculty of Pharmacy and Biotechnology, German University in Cairo, Cairo, Egypt.
  • Pharmaceutical and Medicinal Chemistry, Saarland University, Saarbrücken, Germany.

ORCID-Profile: Habiba G Aboelfotouh

Förderung

  • None

Zitieren

APA

Aboelfotouh, H. G., Abdallah, M., Khalifa, H., Aboushady, Y., Abadi, A. H., Engel, M., & Abdel-Halim, M. (2024). N 1 ‐Benzoylated 5‐(4‐pyridinyl)indazole‐based kinase inhibitors: Attaining haspin and Clk4 selectivity via modulation of the benzoyl substituents. Archiv der Pharmazie. https://doi.org/10.1002/ardp.202400020

Vancouver

Aboelfotouh HG, Abdallah M, Khalifa H, Aboushady Y, Abadi AH, Engel M, et al. N 1 ‐Benzoylated 5‐(4‐pyridinyl)indazole‐based kinase inhibitors: Attaining haspin and Clk4 selectivity via modulation of the benzoyl substituents. Archiv der Pharmazie. 2024. doi:10.1002/ardp.202400020

BibTeX
@article{Aboelfotouh2024,
  author = {Aboelfotouh, Habiba G and Abdallah, Mennatallah and Khalifa, Hend and Aboushady, Youssef and Abadi, Ashraf H and Engel, Matthias and Abdel-Halim, Mohammad},
  title = {N 1 ‐Benzoylated 5‐(4‐pyridinyl)indazole‐based kinase inhibitors: Attaining haspin and Clk4 selectivity via modulation of the benzoyl substituents},
  journal = {Archiv der Pharmazie},
  year = {2024},
  doi = {10.1002/ardp.202400020}
}
Kostenlos starten →